Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.

Saved in:
Bibliographic Details
Title: Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.
Authors: Spellberg B; Division of Infectious Diseases, Harbor-University of California at Los Angeles Medical Center, Torrance, California 90502, USA. bspellberg@labiomed.org, Talbot GH, Boucher HW, Bradley JS, Gilbert D, Scheld WM, Edwards J Jr, Bartlett JG
Corporate Authors: Antimicrobial Availability Task Force of the Infectious Diseases Society of America
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2009 Aug 01; Vol. 49 (3), pp. 383-91.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 19555285
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spellberg+B%22">Spellberg B</searchLink>; Division of Infectious Diseases, Harbor-University of California at Los Angeles Medical Center, Torrance, California 90502, USA. bspellberg@labiomed.org<br /><searchLink fieldCode="AU" term="%22Talbot+GH%22">Talbot GH</searchLink><br /><searchLink fieldCode="AU" term="%22Boucher+HW%22">Boucher HW</searchLink><br /><searchLink fieldCode="AU" term="%22Bradley+JS%22">Bradley JS</searchLink><br /><searchLink fieldCode="AU" term="%22Gilbert+D%22">Gilbert D</searchLink><br /><searchLink fieldCode="AU" term="%22Scheld+WM%22">Scheld WM</searchLink><br /><searchLink fieldCode="AU" term="%22Edwards+J+Jr%22">Edwards J Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Bartlett+JG%22">Bartlett JG</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Antimicrobial+Availability+Task+Force+of+the+Infectious+Diseases+Society+of+America%22">Antimicrobial Availability Task Force of the Infectious Diseases Society of America</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2009 Aug 01; Vol. 49 (3), pp. 383-91.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19555285
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1086/600296
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 383
    Titles:
      – TitleFull: Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spellberg B
      – PersonEntity:
          Name:
            NameFull: Talbot GH
      – PersonEntity:
          Name:
            NameFull: Boucher HW
      – PersonEntity:
          Name:
            NameFull: Bradley JS
      – PersonEntity:
          Name:
            NameFull: Gilbert D
      – PersonEntity:
          Name:
            NameFull: Scheld WM
      – PersonEntity:
          Name:
            NameFull: Edwards J Jr
      – PersonEntity:
          Name:
            NameFull: Bartlett JG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2009 Aug 01
              Type: published
              Y: 2009
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 49
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1